Related Experiment Video
Updated: Mar 25, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
21.1K
[Lung sarcoidosis: Clinical features and therapeutic issues]
Y Uzunhan1, F Jeny1, F Crockett2
1Service de pneumologie, hôpital Avicenne, hôpitaux universitaires Paris Seine Saint-Denis, AP-HP, 125, rue de Stalingrad, 93000 Bobigny, France; Université Paris 13, COMUE Sorbonne Paris-Cité, EA 2363 « Hypoxie et Poumon », 74, rue Marcel-Cachin, 93000 Bobigny, France.
La Revue De Medecine Interne
|February 22, 2016
Summary
Sarcoidosis is a granulomatous disease often affecting the lungs. Diagnosis requires specific clinical signs, imaging, and biopsy, with treatment strategies ranging from corticosteroids to newer therapies for advanced cases.
Area of Science:
- Pulmonology
- Immunology
- Rheumatology
Background:
- Sarcoidosis is an idiopathic granulomatous disease with frequent lung involvement.
- Its clinical course is unpredictable, necessitating accurate diagnosis.
- Diagnosis relies on clinical presentation, imaging, and non-caseating granulomas, excluding other diseases.
Purpose of the Study:
- To provide an overview of sarcoidosis diagnosis and management.
- To highlight the importance of biopsy site selection.
- To discuss current and emerging therapeutic strategies.
Main Methods:
- Review of diagnostic criteria for sarcoidosis.
- Analysis of treatment guidelines and emerging therapies.
- Discussion of prognostic factors and complications.
Main Results:
- Superficial lesion biopsy is preferred over endoscopic methods.
- Corticosteroids are first-line treatment for approximately half of patients.
- Immunosuppressants and anti-TNFα agents are second and third-line options.
Conclusions:
- Sarcoidosis management requires careful consideration of spontaneous resolution and treatment risks.
- Advanced pulmonary sarcoidosis leads to significant morbidity and mortality.
- Pharmacogenetics holds promise for personalized sarcoidosis treatment.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
2.2K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K
01:17Other Pulmonary Disorders
2.0K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
2.0K
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.1K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.1K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:28Pulmonary Tuberculosis II
2.0K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.0K
01:20Asthma: Pathogenesis and Management
1.7K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K